MarisaTTungsiripatMD
Infectious Disease • Cleveland, OHAssistant Professor, Medicine, Case Western Reserve University School of Medicine
Dr. Tungsiripat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 2004
Yale-New Haven Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Missouri Kansas City School of MedicineClass of 1995
Certifications & Licensure
OH State Medical License 1998 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy Start of enrollment: 2005 May 01
- Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression Start of enrollment: 2010 Oct 01
Publications & Presentations
PubMed
- 113 citationsCurrent concepts in the diagnosis and management of metabolic complications of HIV infection and its therapyDavid A. Wohl, Grace A. McComsey, Pablo Tebas, Todd T. Brown, Marshall J. Glesby
Clinical Infectious Diseases. 2006-09-01 - 191 citationsRelationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral TherapyAllison C. Ross, Nesrine Rizk, Mary Ann O'Riordan, Vikram S. Dogra, Dalia El-Bejjani
Clinical Infectious Diseases. 2009-10-01 - 25 citationsRosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens.Marisa Tungsiripat, Dalia El Bejjani, Nesrine Rizk, Mary Ann O'Riordan, Allison C. Ross
AIDS. 2010-06-01
Grant Support
- Metabolic Complications Of HIV And Responses To PioglitazoneNational Institute Of Allergy And Infectious Diseases2007–2011
Other Languages
- Thai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
